Blockade of the cannabinoid CB1 receptor and alcohol dependence: Preclinical evidence and preliminary clinical data

CNS and Neurological Disorders - Drug Targets

Volumn 9, Issue 1, 2010, Pages 55-59

  Maccioni, Paola ^a   Colombo, Giancarlo ^a   Carai, Mauro A M ^a  

^a CNR   (Italy)

Author keywords

Alcohol; Alcohol relapse; Animal models of alcoholism; Rimonabant

Indexed keywords

ALCOHOL; CANNABINOID 1 RECEPTOR ANTAGONIST; NALOXONE; NALTREXONE; PLACEBO; RIMONABANT; WATER; CANNABINOID; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; NARCOTIC ANTAGONIST; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; CLINICAL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG POTENTIATION; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; EVIDENCE BASED PRACTICE; EXPERIMENTAL MODEL; HUMAN; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; MENTAL DISEASE; NONHUMAN; PROPHYLAXIS; RECURRENT DISEASE; REVIEW; TASK PERFORMANCE; TIME PERCEPTION; WISTAR RAT; ANIMAL; ANIMAL MODEL; BRAIN; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ALCOHOLISM; ANIMALS; BRAIN; CANNABINOIDS; DISEASE MODELS, ANIMAL; ENDOCANNABINOIDS; HUMANS; MODELS, ANIMAL; NARCOTIC ANTAGONISTS; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1;

EID: 77949901974     PISSN: 18715273     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152710790966623     Document Type: Review

References (66)

1. 1 receptor agonist. Eur. J. Pharmacol., 1999, 370, 233-240.
2. Colombo, G.; Serra, S.; Brunetti, G.; Gómez, R.; Melis, S.; Vacca, G.; Carai, M.A.M.; Gessa, G.L. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology, 2002, 159, 181-187.
3. Wang, L.; Liu, J.; Harvey-White, J.; Zimmer, A.; Kunos, G. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc. Natl. Acad. Sci. USA, 2003, 100, 1393-1398.
4. López-Moreno, J.A.; González-Cuevas, G.; Rodríguez de Fonseca, F.; Navarro, M. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. J. Neurosci., 2004, 24, 8245-8252.
5. Kelaï, S.; Hanoun, N.; Aufrère, G.; Beaugé, F.; Hamon, M.; Lanfumey, L. Cannabinoid-serotonin interactions in alcohol-preferring vs alcohol-avoiding mice. J. Neurochem., 2006, 99, 308-320.
6. Malinen, H.; Hyytiä, P. Ethanol self-administration is regulated by CB1 receptors in the nucleus accumbens and ventral tegmental area in alcohol-preferring AA rats. Alcohol. Clin. Exp. Res., 2008, 32, 1976-1983.
7. 1 receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse, 2008, 62, 574-581.
8. Alén, F.; Santos, A.; Moreno-Sanz, G.; González-Cuevas, G.; Giné, E.; Franco-Ruiz, L.; Navarro, M.; López-Moreno, J.A. Cannabinoid-induced increase in relapse-like drinking is prevented by the blockade of the glycine-binding site of N-methyl-D-aspartate receptors. Neuroscience, 2009, 158, 465-473.
9. 1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J. Neurochem., 2003, 84, 698-704.
10. 1 receptor deleted mice. Neurosci. Lett., 2003, 343, 216-218.
11. 1 receptor knockout mice. Neuropharmacology, 2004, 46, 243-253.
12. 1 cannabinoid receptor knockout mice while decreasing ethanol preference. Alcohol Alcohol., 2005, 40, 54-62.
13. 1 receptors. Behav. Brain Res., 2005, 164, 206-213.
14. 1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J. Neurosci., 2003, 23, 2453-2458.
15. Di Marzo, V.; Petrocellis, L.D. Plant, synthetic, and endogenous cannabinoids in medicine. Annu. Rev. Med., 2006, 57, 553-574.
16. Solinas, M.; Goldberg, S.R.; Piomelli, D. The endocannabinoid system in brain reward processes. Br. J. Pharmacol., 2008, 154, 369-383.
17. Freund, T.F.; Katona, I.; Piomelli, D. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev., 2003, 83, 1017-1066.
18. Serra, S.; Carai, M.A.M.; Brunetti, G.; Gómez, R.; Melis, S.; Vacca, G.; Colombo, G.; Gessa, G.L. The cannabinoid receptor antagonist SR 141716 prevents acquisition of drinking behaviour in alcohol-preferring rats. Eur. J. Pharmacol., 2001, 430, 369-371.
19. Bell, R.L.; Rodd, Z.A.; Sable, H.J.K.; McQueen, V.K.; Davids, M.R.; Murphy, J.M.; Lumeng, L.; McBride, W.J. Cannabinoid CB1 antagonist reduces alcohol intake during acquisition, maintenance, and relapse in inbred alcohol preferring (IP) rats. Program No. 489.6., 2004, Abstract Viewer/Itinerary Planner, Society for Neuroscience: Washington DC.
20. 1) receptors. Psychopharmacology, 1997, 132, 104-106.
21. 1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol. Clin. Exp. Res., 2001, 25, 1317-1323.
22. 1 cannabinoid receptor: biochemical and pharmacological characterization. J. Pharmacol. Exp. Ther., 2004, 310, 905-914.
23. 1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol., 2005, 40, 46-53.
24. Colombo, G.; Agabio, R.; Fà, M.; Guano, L.; Lobina, C.; Loche, A.; Reali, R.; Gessa, G.L. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR 141716. Alcohol Alcohol., 1998, 33, 126-130.
25. 1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence. Mol. Neurobiol., 2007, 36, 102-112.
26. 1 receptor antagonist rimonabant (SR-141716) on ethanol drinking in high-preferring rats. Alcohol, 2008, 42, 509-512.
27. 1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals. Alcohol Alcohol., 2004, 39, 486-492.
28. 1 receptor antagonists in reducing food intake and body weight: preclinical and clinical data. CNS Drug Rev., 2006, 12, 91-99.
29. Isoldi, K.K.; Aronne, L.J. The challenge of treating obesity: the endocannabinoid system as a potential target. J. Am. Diet. Assoc., 2008, 108, 823-831.
30. Akbas, F.; Gasteyger, C.; Sjödin, A.; Astrup, A.; Larsen, T.M. A critical review of the cannabinoid receptor as a drug target for obesity management. Obes. Rev., 2009, 10, 58-67.
31. Leite, C.E.; Mocelin, C.A.; Petersen, G.O.; Leal, M.B.; Thiesen, F.V. Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity. Pharmacol. Rep. 2009, 61, 217-224.
32. 1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats. Alcohol, 2006, 39, 125-134.
33. 1 receptor inverse agonist AM251 attenuates alcohol self-administration and the alcohol deprivation effect. Program No. 117.11., 2004, Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington DC.
34. Pavon, F.J.; Bilbao, A.; Hernández-Folgado, L.; Cippitelli, A.; Jagerovic, N.; Abellán, G.; Rodríguez-Franco, M.A.; Serrano, A.; Macias, M.; Gómez, R.; Navarro, M.; Goya, P.; Rodríguez de Fonseca, F. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole - LH 21. Neuropharmacology, 2006, 51, 358-366.
35. Spanagel, R. How to measure relapse in animals. In Drugs for Relapse Prevention of Alcoholism; Spanagel, R.; Mann, K., Eds.; Birkäuser Verlag: Basel, 2005; pp. 13-21.
36. 1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur. J. Pharmacol., 2002, 443, 95-97.
37. Gallate, J.E.; Mallet, P.E.; McGregor, I.S. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology, 2004, 173, 210-216.
38. Carai, M.A.M.; Lobina, C.; Gessa, G.L.; Colombo, G. Cannabinoid receptor antagonists: a perspective. In Drugs for Relapse Prevention of Alcoholism; Spanagel, R.; Mann, K., Eds.; Birkäuser Verlag: Basel, 2005; pp. 181-187.
39. Colombo, G.; Serra, S.; Vacca, G.; Carai, M.A.M.; Gessa, G.L. Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol. Biochem. Behav., 2005, 81, 369-380.
40. Corchero, J.; Manzanares, J.; Fuentes, J.A. Cannabinoid/opioid crosstalk in the central nervous system. Crit. Rev. Neurobiol., 2004, 16, 159-172.
41. Cota, D.; Tschop, M.H.; Horvath, T.L.; Levine, A.S. Cannabinoids, opioids and eating behavior: the molecular face of hedonism? Brain Res. Rev., 2006, 51, 85-107.
42. Manzanares, J.; Ortiz, S.; Oliva, J.M.; Perez-Rial, S.; Palomo, T. Interactions between cannabinoid and opioid receptor systems in the mediation of ethanol effects. Alcohol Alcohol., 2005, 40, 25-34.
43. Rodd, Z.A.; Bell, R.L.; Pommer, T.J.; McQueen, V.K.; Lumeng, L.; Murphy, J.M.; McKinzie, D.L.; McBride, W.L. The CB1 antagonist SR141716 transiently reduces operant ethanol self-administration during relapse and maintenance, and inhibits alcohol seeking in alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res., 2005, 29(Suppl), 19A.
44. Hansson, A.C.; Bermudez-Silva, F.J.; Malinen, H.; Hyytiä, P.; Sanchez-Vera, I.; Rimondini, R.; Rodriguez de Fonseca, F.; Kunos, G.; Sommer, W.H.; Heilig, M. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology, 2007, 32, 117-126.
45. 1 receptor antagonist, rimonabant, on alcohol self-administration in alcohol-preferring rats. Open Neuropsychopharmacol. J., 2009, 2, 40-44.
46. 1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur. J. Neurosci., 2005, 21, 2243-2251.
47. Parsons, L.H. Evidence for an endocannabinoid influence in the regulation of ethanol self-administration. Alcohol. Clin. Exp. Res., 2005, 29(Suppl), 12A.
48. 1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Psychopharmacology, 2006, 183, 394-403.
49. Weiss, F.; Porrino, L. Behavioral neurobiology of alcohol addiction: recent advances and challenges. J. Neurosci., 2002, 22, 3332-3337.
50. Vengeliene, V.; Bilbao, A.; Molander, A.; Spanagel, R. Neuropharmacology of alcohol addiction. Br. J. Pharmacol., 2008, 154, 299-315.
51. 1 receptors in the regulation of ethanol self-administration by Wistar rats. Open Neuropsychopharmacol. J., 2009, 2, 77-85.
52. Caillé S.; Alvarez-Jaimes, L.; Polis, I.; Stouffer, D.G.; Parsons, L.H. Specific alterations of extracellular endocannabinoid levels in the nucleus accumbs by ethanol, heroin, and cocaine self-administration. J. Neurosci., 2007, 27, 3695-3702.
53. 1) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav. Pharmacol., 2002, 13, 451-463.
54. Cheer, J.F.; Wassum, K.M.; Sombers, L.A.; Heien, M.L.; Ariansen, J.L.; Aragona, B.J.; Phillips, P.E.; Wightman, R.M. Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J. Neurosci., 2007, 27, 791-795.
55. Perra, S.; Pillolla, G.; Melis, M.; Muntoni, A.L.; Gessa, G.L.; Pistis, M. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo. Psychopharmacology 2005, 183, 368-377.
56. Freedland, C.S.; Sharpe, A.L.; Samson, H.H.; Porrino, L.J. Effects of SR 1417161A on alcohol and sucrose self-administration. Alcohol. Clin. Exp. Res., 2001, 25, 277-282.
57. Gallate, J.E.; McGregor, I.S. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology, 1999, 142, 302-308.
58. 1 receptor antagonist, SR 141716, on alcohol's motivational properties in alcohol-preferring rats. Eur. J. Pharmacol., 2004, 498, 119-123.
59. 1 receptor agonism (CP-55940). Behav. Pharmacol., 2005, 16, 381-388.
60. Evenden, J.; Ko, T. The effects of anorexic drugs on free-fed rats responding under a second-order FI15-min (FR10:S) schedule for high incentive foods. Behav. Pharmacol., 2007, 18, 61-69.
61. 1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behav. Pharmacol., 2008, 19, 197-209.
62. Lê, A.; Shaham, Y. Neurobiology of relapse to alcohol in rats. Pharmacol. Ther., 2002, 94, 137-156.
63. 9-THC reinstates beer- and sucrose-seeking behaviour in abstinent rats: comparison with midazolam, food deprivation and predator odour. Alcohol Alcohol., 2005, 40, 35-45.
64. 1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol. Neurobiol. Dis., 2007, 25, 274-283.
65. Soyka, M.; Koller, G.; Schmidt, P.; Lesch, O.M.; Leweke, M.; Fehr, C.; Gann, H.; Mann, K.F.; ACTOL Study Investigators. Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J. Clin. Psychopharmacol., 2008, 28, 317-324.
66. George, D.T.; Herion, D.W.; Jones, C.L.; Phillips, M.J.; Hersh, J.; Hill, D.; Heilig, M.; Ramchandani, V.A.; Geyer, C.; Spero, D.E.; Singley, E.D.; O'Malley, S.S.; Bishai, R.; Rawlings, R.R.; Kunos, G. Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology, 2009, (in press).